Artivion Inc AORT

NYS: AORT | ISIN: US2289031005   22/12/2025
46,87 USD (+0,69%)
(+0,69%)   22/12/2025

6 november 2025 · Artivion Reports Third Quarter 2025 Financial Results · Persbericht

6 november 2025 · Artivion Announces Treatment of First Patient with Arcevo LSA in ARTIZEN Pivotal Trial · Persbericht

29 oktober 2025 · Artivion to Participate in the Stifel 2025 Healthcare Conference · Persbericht

23 oktober 2025 · Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results · Persbericht

13 oktober 2025 · Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting · Persbericht

5 september 2025 · Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference · Persbericht

7 augustus 2025 · Artivion Reports Second Quarter 2025 Financial Results · Persbericht

30 juli 2025 · Artivion to Participate in Upcoming Investor Conferences · Persbericht

24 juli 2025 · Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2025 Financial Results · Persbericht

3 juni 2025 · Artivion to Participate in Upcoming Investor Conferences · Persbericht

28 mei 2025 · Artivion Announces Closing of Transactions to Exchange $99.5 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock · Persbericht

14 mei 2025 · Artivion Announces Agreements to Exchange $95 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock · Persbericht

5 mei 2025 · Artivion Reports First Quarter 2025 Financial Results · Persbericht

5 mei 2025 · Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting · Persbericht

21 april 2025 · Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results · Persbericht

4 maart 2025 · Artivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference · Persbericht

8 augustus 2024 · Artivion Reports Second Quarter 2024 Financial Results · Persbericht

5 augustus 2024 · Artivion to Participate in Upcoming Investor Conferences · Persbericht

25 juli 2024 · Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results · Persbericht

1 juli 2024 · Artivion Amends Agreements with Endospan · Persbericht

Mijn selecties